A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2011
10/05/2011	EP1562577B1 Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by thalidomide
10/05/2011	EP1463497B1 Treating muscle wasting with selective androgen receptor modulators
10/05/2011	EP1411052B1 Benzo-fused 5-membered hetrocycle compounds,process for preparation of the same, and use thereof
10/05/2011	EP1395279B1 Use of neublastin polypeptides for treating neuropathic pain
10/05/2011	EP1377276B1 Timed pulse release composition
10/05/2011	CN1872218B Effervesce agent for treating headache, and preparation method
10/05/2011	CN1872217B A medication for treating headache, and preparation method
10/05/2011	CN1817883B New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
10/05/2011	CN102209721A Spiro-tetracyclic ring compounds as betasecretase modulators and methods of use
10/05/2011	CN102209718A Carbamate compound or salt thereof
10/05/2011	CN102209713A 1- (arylsulfonyl) -4- (pi perazin-i -yl) -ih-benz imidazoles as d-hydroxytryptamine- 6 ligands
10/05/2011	CN102209540A Treatment with alpha a7-selective ligands
10/05/2011	CN102206285A Chimeric peptide based on endomorphins 2 and neuropeptides FF, and synthesis and application thereof
10/05/2011	CN102206277A Antibodies that bind human interleukin-18 and methods of making and using
10/05/2011	CN102206214A Benzopyrone derivative and application thereof
10/05/2011	CN102206204A Benzimidazole compound and medicinal application thereof
10/05/2011	CN102206195A Crystalline quetiapine fumarate and pharmaceutical compositions thereof
10/05/2011	CN102205127A Administration of capsaicinoids
10/05/2011	CN102205114A Application of erythropoietin source peptide to preparation of medicament for treating autoimmune disease of nervous system
10/05/2011	CN102205113A Novel application of Jingzhaotoxin
10/05/2011	CN102205060A Chinese medicinal preparation for treating vascular dementia caused by cerebral arteriosclerosis
10/05/2011	CN102205033A Preparation method of traditional Chinese medicine for treating headache-type influenza in children
10/05/2011	CN102205032A Golden mushroom oral liquid for treating hyperactivity disease
10/05/2011	CN102205014A Method for processing rhizoma arisaematis
10/05/2011	CN102205013A Method for processing giant typhonium rhizome
10/05/2011	CN102205001A Traditional Chinese medicine for treating neuropathic heart disease
10/05/2011	CN102204978A Medicinal composition for treating cancer pain and preparation thereof
10/05/2011	CN102204967A Preparation method for safflower care-free tablet
10/05/2011	CN102204959A Medicament for treating epilepsy
10/05/2011	CN102204941A Antidepressant effect and application of effective parts of hypericum wightianum
10/05/2011	CN102204937A Pyrola extract and preparation method and application thereof
10/05/2011	CN102204930A Improved modalities for the treatment of degenerative diseases of the retina
10/05/2011	CN102204908A Pharmaceutical composition containing edaravone compound, and preparation method thereof
10/05/2011	CN102204904A Application of levorotatory oxiracetamto preparation of medicaments for preventing or treating cognitive dysfunction
10/05/2011	CN102204893A Blonanserin dropping pill and preparation method thereof
10/05/2011	CN102204892A Gingko flavanone aglycone dropping pills and preparation method thereof
10/05/2011	CN102204885A Preparation method of aceglutamide glucose injection
10/05/2011	CN102204883A Promethazine hydrochloride microenema prescription and preparation method thereof
10/05/2011	CN102204703A Small shallot oral liquid and preparation method thereof
10/05/2011	CN101966235B Medicament for treating migraine and preparation method thereof
10/05/2011	CN101756902B Clonidine multivesicular liposome and preparation method thereof
10/05/2011	CN101732322B Application of corosolic acid in preparation of antidepressant drug
10/05/2011	CN101716204B Anticancer analgesic preparation and preparation method thereof
10/05/2011	CN101703697B Chinese patent medicament for treating epilepsy and preparation method thereof
10/05/2011	CN101653555B Chinese medicine composition for treating insomnia and anxiety and preparation method thereof
10/05/2011	CN101642450B New application of dicaffeoylquinic acid
10/05/2011	CN101605545B Skin adhesive preparation comprising stabilized donepezil
10/05/2011	CN101548950B Tripterine nanometer lipid injection and method for preparing same
10/05/2011	CN101496863B Chinese medicinal composition for treating anypnia and preparation method thereof
10/05/2011	CN101485866B Chinese medicinal composition for detoxification
10/05/2011	CN101442993B Adhesive preparation
10/05/2011	CN101380464B Method for treating a movement disorder
10/05/2011	CN101348461B N-(3-pyridine formyloxy)-3,5-dimethyl-1-amantadine for curing senile dementia or pharmaceutical salt thereof
10/05/2011	CN101264097B Use of spongosine for the treatment of pain
10/05/2011	CN101224201B Application of dual inhibitor for dopamine and norepinephrine transfer protein
10/05/2011	CN101015575B Process for preparing bupleurum root dropping pills
10/04/2011	USRE42802 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
10/04/2011	US8030517 CCR9 inhibitors and methods of use thereof
10/04/2011	US8030484 Substituted triazines as prion protein ligands and their use to detect or remove prions
10/04/2011	US8030348 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
10/04/2011	US8030314 for the treatment of extrapyramidal movement disorders
10/04/2011	US8030300 2-pyrrolidinyloxy-substituted pyridine; Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder
10/04/2011	US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
10/04/2011	US8030275 Methods for treating obesity using fibroblast growth factor-like polypeptides
10/04/2011	US8029826 Chlorite in the treatment of neurodegenerative disease
10/04/2011	US8029823 Controlled release and taste masking oral pharmaceutical composition
10/04/2011	US8029796 Therapeutic anti-cytomegalovirus compounds
10/04/2011	US8029793 Anticancer agents; rheumatic diseases; osteoporosis; antiinflammatory agents; cloning genes
10/04/2011	US8029781 Methods of treating a deficiency of functional tripeptidyl peptidase I (CLN2) protein
10/04/2011	US8029772 Free-flowing anionic surfactant, alkanolamide and electrolytemixture
10/04/2011	CA2673462C Solid oral dosage forms of valsartan
10/04/2011	CA2620274C Methods for the treatment of senile dementia of the alzheimer's type
10/04/2011	CA2491079C Therapeutic piperazine derivatives useful for treating pain
10/04/2011	CA2453837C Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds
10/04/2011	CA2452871C Oxymorphone controlled release formulations
10/04/2011	CA2438520C Phthalazinone-piperidino-derivatives as pde4 inhibitors
10/04/2011	CA2434773C Piperazinylcarbonylquinolines and -isoquinolines
10/04/2011	CA2426031C 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
10/04/2011	CA2371839C Hydroxymatairesinol in cancer prevention
10/03/2011	WO2011027806A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772922A1 Therapeutic agent for anxiety disorders
10/03/2011	CA2772920A1 Therapeutic agent for mood disorders
09/2011
09/29/2011	WO2011119777A2 Compositions and methods for treatment of neurodegenerative disease
09/29/2011	WO2011119649A2 Pharmaceutical compositions containing berberine for treatment or prevention of weight gain and obesity associated with anti-psychotic drugs
09/29/2011	WO2011119588A1 Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders
09/29/2011	WO2011119565A1 Imaging agents for detecting neurological disorders
09/29/2011	WO2011119136A1 Prophylactic and therapeutic treatment of neuro-degenerative diseases and protein aggregation diseases
09/29/2011	WO2011118891A1 Pharmaceutical composition including sulfuretin or pharmaceutically acceptable salt thereof for prevention and treatment of nervous system disorder
09/29/2011	WO2011118812A1 Neurodegenerative disease therapeutic agent
09/29/2011	WO2011118795A1 Composition for treatment of damaged part
09/29/2011	WO2011118604A1 Hydrous adhesive patch
09/29/2011	WO2011118468A1 Wake-time-extending agent
09/29/2011	WO2011117711A1 Pharmaceutical composition comprising a pyrimidineone derivative
09/29/2011	WO2011117448A1 Compounds for use in the treatment of diseases based on the expression of toxic transcripts
09/29/2011	WO2011117305A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates
09/29/2011	WO2011117289A1 Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
09/29/2011	WO2011117264A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors
09/29/2011	WO2011117163A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators
09/29/2011	WO2011093742A3 Agent for treating parkinson's disease
09/29/2011	WO2011087712A3 Tricyclic derivatives and their pharmaceutical use and compositions

1 ... 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 ... 1833